# PMOS (Formerly PCOS), Hirsutism and Endometriosis for NEET PG OBG: Rotterdam Criteria, Tests, Long-term Risks, Treatment and Endometriosis Basics

Source: https://tracknation.in/story/pmos-formerly-pcos-hirsutism-and-endometriosis-for-neet-pg-obg-rotterdam-criteria-tests-long-term-risks-treatment-and-endometriosis-basics (TrackNation — free UPSC notes with PYQs)

> NEET PG Gynaecology: the new name polyendocrine metabolic ovarian syndrome (formerly PCOS), Rotterdam 2-of-3 criteria and ultrasound definition, tests to exclude mimics, tumour cut-offs, endometrial and metabolic risks, treatment and ovulation induction, hirsutism, and endometriosis sites, theories, triad and stepwise treatment, with a diagram, hooks, MCQs and cards.

## Start Here

🎯 **Exam priority: Very high.** *Expect: Rotterdam criteria, the ultrasound definition of polycystic ovaries, which tests exclude CAH,
Cushing, tumours, hyperprolactinaemia and thyroid disease, why endometrial cancer risk rises, first-line treatment and ovulation induction,
hirsutism vs virilisation, and endometriosis sites, triad and treatment.*

CBME mapping: **OG30**. Note: MSD now calls PCOS **polyendocrine metabolic ovarian syndrome (PMOS)** — exams may use either name.

*PMOS criteria, tests, risks and treatment; endometriosis essentials. Drawn by TrackNation.*

## PMOS (Formerly PCOS): Diagnosis (MSD)

- Affects **5–10% of women**; the renaming stresses hormonal and **metabolic** risks (insulin resistance is thought to be the
initial abnormality) rather than "cysts".

- **Rotterdam — any 2 of 3**: **oligo/anovulation**; **clinical or biochemical hyperandrogenism**; **polycystic ovaries** =
**≥12 follicles of 2–9 mm in each ovary** and/or ovarian volume **>10 ml** on TVS (TVS is **not done in adolescents**).

- Exclude mimics: **pregnancy test, FSH, prolactin, TSH**; early-morning **17-hydroxyprogesterone** (non-classic CAH); **cortisol**
(Cushing). Tumour clues: testosterone **>150 ng/dl**, DHEAS **>800 mcg/dl** (adrenal), or **virilisation** (clitoromegaly, deep
voice, male-pattern baldness).

- Features: irregular periods, hirsutism, acne, obesity, **acanthosis nigricans** (from high insulin), infertility.

## PMOS: Risks and Treatment (MSD)

- Long-term: **unopposed oestrogen → endometrial hyperplasia and cancer**; **type 2 diabetes, impaired glucose tolerance**,
dyslipidaemia, hypertension, sleep apnoea, fatty liver, depression and anxiety.

- Treatment: **weight loss and exercise** (can restore ovulation); **combined pills or progestins** to regulate cycles and protect the
endometrium (antiandrogenic progestins: drospirenone, dienogest); **metformin** for insulin resistance.

- Infertility: MSD's PMOS chapter lists **clomiphene as first-line** with letrozole as an option, while its ovulatory-dysfunction chapter
says many clinicians now **prefer letrozole** (better in obese women) — know both.

- **Hirsutism**: PMOS is the **commonest cause**; others — CAH, Cushing, adrenal/ovarian tumours, drugs. Antiandrogens (spironolactone
25–100 mg twice daily, finasteride) **only with reliable contraception**; plus hair removal methods.

## Endometriosis (MSD)

- Endometrial tissue outside the uterus — commonly **ovaries, broad ligaments, posterior cul-de-sac, uterosacral ligaments**,
peritoneum; also caesarean scars, bowel, bladder, rarely lung/pleura.

- Theories: **retrograde menstruation** (most accepted), coelomic metaplasia, Müllerian rests.

- **Triad: dysmenorrhoea, dyspareunia, infertility** (± dysuria, dyschezia). **Symptom severity does not match stage.**
Infertility: endometriomas destroy follicles (low reserve), adhesions, luteinised unruptured follicle, raised peritoneal prostaglandins and macrophage activity.

- Diagnosis is often **clinical** (± TVS/MRI); **laparoscopy** (± biopsy) helps planning but is not required, and lesions are
treated at the same time.

- Treatment ladder: **NSAIDs + hormonal contraceptives** → **GnRH analogues, aromatase inhibitors or danazol**, or laparoscopic
excision/ablation → if severe and family complete, **hysterectomy ± bilateral salpingo-oophorectomy**.

## Traps the Examiner Sets

- PCOS needs only 2 of 3 criteria — polycystic ovaries are not mandatory.

- Hirsutism with virilisation = look for a tumour or adrenal cause, not PCOS.

- Endometriosis pain does not correlate with the extent of disease.

- Antiandrogens need contraception (fetal risk).

## Memory Hooks & Shortcuts

*Shortcuts to lock in this article's numbers and lists. Each one only re-packages facts proven above.*

- 🧠 **Rotterdam: 'any 2 of A-H-P' — Anovulation, Hyperandrogenism, Polycystic ovaries** — criteria

- 🧠 **PCO on scan '12 follicles, 2–9 mm, 10 ml'** — ultrasound

- 🧠 **Tumour flags '150 and 800': testosterone >150, DHEAS >800** — tumour

- 🧠 **Endometriosis '3 Ds': Dysmenorrhoea, Dyspareunia, Difficulty conceiving** — triad

- 🧠 **'Little disease, lots of pain' — endometriosis stage ≠ symptoms** — staging

## Rapid-Revision Cards

- PMOS (formerly PCOS).

- 5–10%.

- 2 of 3.

- ≥12 follicles 2–9 mm; >10 ml.

- No TVS.

- hCG, FSH, PRL, TSH, 17-OHP, cortisol.

- T >150 ng/dl; DHEAS >800.

- Not PCOS — tumour/adrenal.

- Insulin resistance.

- Unopposed oestrogen.

- T2DM, IGT, OSA.

- Weight loss.

- COC/progestin.

- Letrozole or clomiphene.

- PMOS.

- With contraception.

- Ovary, cul-de-sac, uterosacrals.

- Retrograde menstruation.

- Dysmenorrhoea, dyspareunia, infertility.

- Not related.

- NSAID+OCP → GnRH/AI/danazol → surgery.

## Sources

*Facts in this article were checked against these documents.*

- MSD Manual Professional: Polyendocrine Metabolic Ovarian Syndrome (PMOS); Endometriosis; Ovulatory Dysfunction; Hirsutism and Hypertrichosis — Merck & Co. (MSD Manuals), 2024–26 (link)

- Competency Based Undergraduate Curriculum, Vol III: Obstetrics & Gynaecology (OG30) — National Medical Commission, 2024

## Test Yourself: Practice Questions

Thirty questions in NEET PG style, most of them clinical vignettes.

## Practice Questions (NEET PG pattern)

*Original questions written in the style of the exam: +4 for a correct answer, −1 for a wrong one. Every answer
was checked against the sources listed above. NEET PG papers are not published by NBEMS, so these are not past-paper questions.*

**Q1.** MSD now uses which name for polycystic ovary syndrome?

- (a) Stein–Leventhal disease only

- (b) primary ovarian insufficiency

- (c) ovarian hyperstimulation syndrome

- (d) polyendocrine metabolic ovarian syndrome (PMOS)

**Answer: (d)** — Same condition.

**Q2.** PMOS/PCOS affects about

- (a) 70%

- (b) 0.1%

- (c) 40%

- (d) 5–10% of women

**Answer: (d)** — MSD.

**Q3.** The Rotterdam criteria need

- (a) all 3 features

- (b) polycystic ovaries plus obesity

- (c) any 2 of: anovulation, hyperandrogenism, polycystic ovaries

- (d) raised LH:FSH ratio

**Answer: (c)** — PCO not mandatory.

**Q4.** On ultrasound, polycystic ovarian morphology is

- (a) a single 5 cm cyst

- (b) a dermoid

- (c) ≥12 follicles of 2–9 mm per ovary and/or volume >10 ml

- (d) ≥5 follicles of 20 mm

**Answer: (c)** — MSD.

**Q5.** A 15-year-old with irregular periods and acne is suspected of PCOS. Which test is avoided at this age per MSD?

- (a) prolactin

- (b) transvaginal ultrasound

- (c) serum testosterone

- (d) TSH

**Answer: (b)** — Not in adolescents.

**Q6.** To exclude non-classic congenital adrenal hyperplasia in a hirsute woman, measure

- (a) AMH

- (b) estradiol

- (c) CA-125

- (d) early-morning 17-hydroxyprogesterone

**Answer: (d)** — MSD.

**Q7.** A woman with hirsutism has testosterone of 220 ng/dl. Suspect

- (a) an androgen-secreting tumour

- (b) simple PCOS

- (c) normal variation

- (d) hypothyroidism

**Answer: (a)** — >150 ng/dl.

**Q8.** Markedly raised DHEAS (>800 mcg/dl) suggests

- (a) pregnancy

- (b) ovarian PCOS

- (c) an adrenal androgen-secreting tumour

- (d) Cushing's disease only

**Answer: (c)** — MSD.

**Q9.** A hirsute woman develops clitoromegaly and a deep voice over 6 months. This virilisation suggests

- (a) an androgen-secreting tumour or adrenal cause

- (b) constitutional hirsutism

- (c) drug-free normal

- (d) uncomplicated PCOS

**Answer: (a)** — Investigate urgently.

**Q10.** Before diagnosing PCOS, which tests exclude mimics?

- (a) CA-125 only

- (b) HbA1c only

- (c) karyotype

- (d) pregnancy test, FSH, prolactin, TSH (± cortisol)

**Answer: (d)** — MSD.

**Q11.** Velvety dark skin on the neck in a woman with PCOS reflects

- (a) insulin resistance (acanthosis nigricans)

- (b) vitiligo

- (c) high oestrogen

- (d) Addison disease

**Answer: (a)** — MSD.

**Q12.** Why is endometrial cancer risk raised in chronic anovulatory PCOS?

- (a) high FSH

- (b) unopposed oestrogen without cyclical progesterone

- (c) high progesterone

- (d) low oestrogen

**Answer: (b)** — Protect with progestin.

**Q13.** A metabolic complication more common in PCOS is

- (a) hyperthyroidism

- (b) osteoporosis in youth

- (c) hypocalcaemia

- (d) type 2 diabetes and impaired glucose tolerance

**Answer: (d)** — Also sleep apnoea.

**Q14.** First step for an obese woman with PCOS and irregular cycles:

- (a) immediate IVF

- (b) danazol

- (c) hysterectomy

- (d) weight loss and regular exercise

**Answer: (d)** — May restore ovulation.

**Q15.** For cycle control and endometrial protection in PCOS (no pregnancy wish), use

- (a) combined oral contraceptives or progestins

- (b) GnRH agonists long-term

- (c) oestrogen alone

- (d) clomiphene

**Answer: (a)** — MSD.

**Q16.** Antiandrogenic progestins used in PCOS include

- (a) drospirenone and dienogest

- (b) medroxyprogesterone only

- (c) danazol

- (d) levonorgestrel and norgestrel

**Answer: (a)** — MSD.

**Q17.** An obese woman with PCOS wants to conceive. MSD says many clinicians prefer

- (a) letrozole

- (b) spironolactone

- (c) danazol

- (d) combined pills

**Answer: (a)** — Clomiphene also first-line in PMOS chapter.

**Q18.** MSD's PMOS chapter names the first-line infertility drug as

- (a) IVF

- (b) clomiphene (letrozole also used)

- (c) gonadotropins

- (d) metformin alone

**Answer: (b)** — Know both views.

**Q19.** The commonest cause of hirsutism is

- (a) PMOS (PCOS)

- (b) ovarian Sertoli–Leydig tumour

- (c) Cushing syndrome

- (d) adrenal carcinoma

**Answer: (a)** — MSD.

**Q20.** Spironolactone for hirsutism in a sexually active woman must be combined with

- (a) oestrogen alone

- (b) reliable contraception

- (c) metformin

- (d) nothing

**Answer: (b)** — Fetal risk.

**Q21.** Common sites of endometriosis include

- (a) ovaries, posterior cul-de-sac and uterosacral ligaments

- (b) liver and spleen

- (c) kidneys only

- (d) brain

**Answer: (a)** — MSD.

**Q22.** The most widely accepted theory of endometriosis is

- (a) infection

- (b) trauma

- (c) retrograde menstruation

- (d) coelomic metaplasia only

**Answer: (c)** — Also metaplasia, rests.

**Q23.** The classic triad of endometriosis is

- (a) fever, pain, discharge

- (b) hirsutism, acne, obesity

- (c) amenorrhoea, galactorrhoea, headache

- (d) dysmenorrhoea, dyspareunia, infertility

**Answer: (d)** — ± dyschezia.

**Q24.** A woman with minimal endometriosis at laparoscopy has severe pain. This is

- (a) expected — severity does not match stage

- (b) a sign of cancer

- (c) proof of another cause

- (d) impossible

**Answer: (a)** — MSD.

**Q25.** Endometriomas can impair fertility by

- (a) raising sperm count

- (b) blocking the cervix

- (c) destroying primordial follicles (reduced reserve)

- (d) causing hyperprolactinaemia

**Answer: (c)** — Also adhesions.

**Q26.** A painful nodule in a caesarean scar may be

- (a) scar endometriosis

- (b) hernia only

- (c) keloid

- (d) lipoma

**Answer: (a)** — MSD.

**Q27.** Is laparoscopy mandatory before treating suspected endometriosis?

- (a) No — treatment can start on clinical diagnosis

- (b) Only CA-125 is needed

- (c) Yes, always

- (d) Only CT is needed

**Answer: (a)** — Helps planning.

**Q28.** First-line medical treatment of suspected endometriosis is

- (a) NSAIDs plus hormonal contraceptives

- (b) antibiotics

- (c) hysterectomy

- (d) danazol first

**Answer: (a)** — Then GnRH analogues.

**Q29.** If first-line therapy fails, second-line options for endometriosis include

- (a) metformin

- (b) GnRH analogues, aromatase inhibitors or danazol

- (c) oestrogen alone

- (d) clomiphene

**Answer: (b)** — Or laparoscopy.

**Q30.** A 46-year-old with severe endometriosis who has completed her family and failed treatment may be offered

- (a) IVF

- (b) observation only

- (c) clomiphene

- (d) hysterectomy with or without bilateral salpingo-oophorectomy

**Answer: (d)** — MSD.

### Active Recall

From memory: state the Rotterdam criteria and ultrasound definition, list tests to exclude mimics and tumour clues, describe PMOS long-term risks and treatment including ovulation induction, outline hirsutism management, and summarise endometriosis sites, theory, triad, diagnosis and treatment.
